The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South India

CONTEXT: The guideline recommended dose of intravenous (i.v) recombinant tissue-type plasminogen activator (rt-PA) for acute ischemic stroke is 0.9 mg/kg in the European and American populations. In Asiatic population, some studies have shown that a lower dose of i.v rt-PA is equally efficacious. AI...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Siju V., Thaha, Fazil, Krishnan, S. Vimal, Shajan, Athulya, Balakrishnan, Jayaraj Mymbilly, Palatty, Babu Urumese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341265/
https://www.ncbi.nlm.nih.gov/pubmed/28298840
http://dx.doi.org/10.4103/0972-2327.199911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341265/
https://www.ncbi.nlm.nih.gov/pubmed/28298840
http://dx.doi.org/10.4103/0972-2327.199911

Ejemplares similares